Adipositas - Ursachen, Folgeerkrankungen, Therapie 2023; 17(03): 149
DOI: 10.1055/s-0043-1771590
Moderne Adipositas-Medikamente: Verschreibungsdaten und Trends von 2017 bis 2022 aus
den USA
P. Berning
1
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns
Hopkins University School of Medicine, Baltimore
2
Department of Medicine, University Hospital Muenster, Münster, Germany, Muenster
,
O. Dzaye
1
Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns
Hopkins University School of Medicine, Baltimore
› Author Affiliations